Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
33.51
-2.39 (-6.66%)
Aug 13, 2025, 4:00 PM - Market closed
Monopar Therapeutics Employees
As of December 31, 2024, Monopar Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 6 or 60.00% compared to the previous year.
Employees
16
Change (1Y)
6
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,081,774
Market Cap
206.76M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MNPR News
- 2 days ago - Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments - GlobeNewsWire
- 2 months ago - Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers - GlobeNewsWire
- 2 months ago - Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes - GlobeNewsWire
- 3 months ago - Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments - GlobeNewsWire
- 3 months ago - Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025 - GlobeNewsWire
- 3 months ago - Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025 - GlobeNewsWire
- 4 months ago - Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments - GlobeNewsWire
- 7 months ago - Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PRNewsWire